LivingGLP1
Study S000401

A Phase 1, Randomized, Open-label, Single Center, Three Period Cross-over Study to Evaluate the Pharmacokinetics of Single Dose Administration of Cotadutide in Healthy Subjects

Registration

Registration
NCT04091373
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE1
Masking
NONE
Status
COMPLETED
Enrollment
36
Start
2019-09-27
Primary completion
2020-03-06
Lead sponsor
MedImmune LLC
Conditions
Type 2 Diabetes Mellitus
Interventions
COMBINATION_PRODUCT:cotadutide multidose pen injection
Results posted
FALSE
Individual participant data sharing
YES

Registered primary outcomes

  • Area under the plasma concentration time curve [48 hours]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.